This image illustrates the induction of protective antibodies against influenza neuraminidase (NA) protein by seasonal vaccination (syringe). The dynamic flow of light symbolizes the vaccination procedure.
Wang, Yiquan
core
Emergence and spread of NA-I223V and NA-S247N double-mutant A(H1N1)pdm09 influenza viruses with reduced oseltamivir susceptibility in the Netherlands and beyond, 2023 to 2026. [PDF]
Felix Garza Z +11 more
europepmc +1 more source
Signal mining of adverse reactions for neuraminidase inhibitors in pregnant women: a disproportionality analysis based on the FDA adverse event reporting system database. [PDF]
Cao B, Shen M, Du C, Song Q, Ma Z.
europepmc +1 more source
Neuraminidase-Associated Vaginal Dysbiosis Correlates with HPV Infection Across Oncogenic Risk Subtypes. [PDF]
Wang J +7 more
europepmc +1 more source
Repositioning antiviral phytoconstituents as broad-spectrum inhibitors of influenza A neuraminidase and human metapneumovirus fusion protein. [PDF]
Mounadi N +4 more
europepmc +1 more source
Chalcones as a Versatile Antiviral Scaffold: Molecular Targets, ADMET Profiles, and Translational Challenges. [PDF]
Helena AL +6 more
europepmc +1 more source
Characterization of oseltamivir-resistant A(H5N1) clade 2.3.4.4b, genotype D1.1 variants identified in poultry farms of British Columbia, Canada. [PDF]
Cochin M +13 more
europepmc +1 more source
Computational antiviral drug design
This study designed and computational docked a group of ligands intended to find potent inhibitors for Neuraminidase 4 which would have strong interactions with 8 conserved amino acids in the active site. Several trials of ligands were designed based on
Liu, Lishan
core
From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza. [PDF]
Sun Y +4 more
europepmc +1 more source
H1N1 seasonal surge in India, 2026: Emerging public health threat and evidence based preventive strategies. [PDF]
Choudhary OP, Choudhary P.
europepmc +1 more source

